NDC11 81927037501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 81927-0375-01 | 81927-0375 |
| 81927-0375-1 | 81927-0375 |
| 81927-375-01 | 81927-375 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| nelarabine | NELARABINE | Shorla Oncology Inc. | fc401b06-4e3b-413e-a854-3e031c433862 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 81927-375-01 81927-375 81927037501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.